Tevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) saw a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 6,937 shares, a growth of 190.6% from the May 14th total of 2,387 shares. Based on an average daily volume of 113,822 shares, the short-interest ratio is presently 0.1 days.
Tevogen Bio Trading Up 4.8%
Shares of NASDAQ:TVGNW opened at $0.04 on Friday. The firm’s 50-day moving average is $0.04 and its two-hundred day moving average is $0.04. Tevogen Bio has a 1 year low of $0.03 and a 1 year high of $0.08.
Tevogen Bio Company Profile
Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.
The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.
Featured Articles
- Five stocks we like better than Tevogen Bio
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
